Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pinto

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Viruses|October 26, 2021
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 VaccinationCarlos A A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Nature Communications|September 22, 2019
Time elapsed between Zika and dengue virus infections affects antibody and T cell responsesErick X Pérez-Guzmán, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Vaccines|November 26, 2025
CD4<sup>+</sup> T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine DesignAngel E Miranda-Santiago, Crisanta Serrano-Collazo, Lorna A Cruz, et al.
Science (New York, N.Y.)|May 2, 2020
Brazil policy invites marine invasive speciesRicardo J Miranda, José A C C Nunes, Joel C Creed, et al.
Plos One|September 16, 2022
Metal coordinating inhibitors of Rift Valley fever virus replicationElizabeth Geerling, Valerie Murphy, Maria C Mai, et al.
Frontiers in Immunology|September 14, 2023
Identification of immunodominant T cell epitopes induced by natural Zika virus infectionChristopher S Eickhoff, Krystal A Meza, Frances E Terry, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Vaccines|August 28, 2021
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal ChallengeR Glenn King, Aaron Silva-Sanchez, Jessica N Peel, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Msphere|June 15, 2022
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay HarmonizationAmy B Karger, James D Brien, Jayne M Christen, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Viruses|October 26, 2021
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 VaccinationCarlos A A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Nature Communications|September 22, 2019
Time elapsed between Zika and dengue virus infections affects antibody and T cell responsesErick X Pérez-Guzmán, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Vaccines|November 26, 2025
CD4<sup>+</sup> T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine DesignAngel E Miranda-Santiago, Crisanta Serrano-Collazo, Lorna A Cruz, et al.
Science (New York, N.Y.)|May 2, 2020
Brazil policy invites marine invasive speciesRicardo J Miranda, José A C C Nunes, Joel C Creed, et al.
Plos One|September 16, 2022
Metal coordinating inhibitors of Rift Valley fever virus replicationElizabeth Geerling, Valerie Murphy, Maria C Mai, et al.
Frontiers in Immunology|September 14, 2023
Identification of immunodominant T cell epitopes induced by natural Zika virus infectionChristopher S Eickhoff, Krystal A Meza, Frances E Terry, et al.
NPJ Vaccines|April 14, 2026
Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challengeVincent Dussupt, Jaime L Jensen, Angélica Peña Rosado, et al.
Vaccines|August 28, 2021
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal ChallengeR Glenn King, Aaron Silva-Sanchez, Jessica N Peel, et al.
Nature Medicine|February 5, 2020
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donorVincent Dussupt, Rajeshwer S Sankhala, Gregory D Gromowski, et al.
Msphere|June 15, 2022
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay HarmonizationAmy B Karger, James D Brien, Jayne M Christen, et al.
Pageof 11